Lisaftoclax (APG-2575) Combined with Novel Therapeutic Regimens in Patients (pts) with Relapsed or Refractory Multiple Myeloma (R/R MM) or Immunoglobulin Light-Chain (AL) Amyloidosis

Category Primary study
JournalBlood
Year 2024
This article has no abstract
Epistemonikos ID: 2cf89afdc0d1c7eebf3ca61d4a7febfb5178e055
First added on: Jul 12, 2025